Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/06
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 10/31/11
Due: 10/31/12
Phase: N/A
Priority: Normal
Start: 04/30/10
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 10/11/22
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of Chemo-Immunotherapy in Head and Neck Cancer Patients | NCT01149902 | University of Yamanashi | user2@example.com | None | 2010-07-31 | - | - | - | - | 2025-07-14 |
| Peptide Vaccination in Treating Patients With Esophageal Cancer | NCT00682227 | University of Yamanashi | user2@example.com | None | 2006-08-31 | 2009-12-31 | 2010-12-31 | - | - | 2025-07-14 |
| A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | NCT00995358 | University of Yamanashi | user2@example.com | None | 2008-11-30 | 2011-10-31 | 2012-10-31 | - | - | 2025-07-14 |
| Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II) | NCT01267578 | University of Yamanashi | user2@example.com | None | 2010-04-30 | 2012-05-31 | 2013-05-31 | - | - | 2025-07-14 |
| sCLEC-2 in Stroke Study | NCT05579405 | University of Yamanashi | user2@example.com | None | 2022-10-11 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |